Aclarion

Broomfield, United States Founded: 2008 • Age: 18 yrs Listed
SaaS-based radiology image analysis tools are provided for medical providers.

About Aclarion

Aclarion is a publicly listed company based in Broomfield (United States) founded in 2008. SaaS-based radiology image analysis tools are provided for medical providers. Aclarion has raised $3.26 million across 4 funding rounds. The company has 6 employees. Its chief executive, as recorded, is Brent Ness. Aclarion offers products and services including NOCISCAN. Its focus areas include HealthTech, Healthcare IT, Provider and Clinical Operations. Its legal entity is ACLARION, INC. Its competitors include AIdoc, Lantheus and Vista.ai; 2 of its 3 listed competitors have raised funding.

Company details

Founded in 2008 and based in Broomfield, United States, Aclarion operates in the healthcare technology sector. Software is developed to support radiology image analysis through a SaaS model. Raw medical imaging data is processed into metabolic biomarkers, with features enabled for MRI diagnosis and diagnostic analysis. Assistance is offered to providers for enhanced imaging and diagnostic workflows.

  • Headquarters Broomfield, United States
  • Employees 6
  • Stage Public
  • Sectors
    Healthcare
  • Email
    ••••••••
  • Phone
    •••• ••••
  • Website aclarion.com
  • Social LinkedIn X
  • Legal Name Aclarion, Inc.
Key Metrics
  • Annual Revenue
    $75.73 K (USD)
    65.62
    as on Dec 31, 2025
  • Net Profit
    -$7.23 M (USD)
    -3.44
    as on Dec 31, 2025
  • EBITDA
    -$6.82 M (USD)
    -28.29
    as on Dec 31, 2025
  • Total Equity Funding
    $3.26M (USD)

    in 4 rounds

  • Latest Funding Round
    $20M (USD), Post-IPO

    Feb 2025

  • Employee Count
    6

Products & Services of Aclarion

Aclarion offers a comprehensive portfolio of products and services, including NOCISCAN.

NOCISCAN
Diagnostic Platform

Uses MR Spectroscopy to identify painful spinal discs noninvasively.

Funding Insights of Aclarion

Aclarion has successfully raised a total of $3.26M across 4 strategic funding rounds. The most recent funding activity was a Post-IPO round of $20 million completed in February 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $3.26M
  • Total Rounds 4
  • Last Round Post-IPO — $20M
  • First Round $3.26M

    (May 2018)

All 4 funding rounds of Aclarion with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Feb 2025$20MPost-IPO––
–
Sep 2024$1MPost-IPO––
–
May 2023$2MPost-IPO––
–
May 2018$3.26MSeries A––
–

People of Aclarion

4 people are tracked at Aclarion (4 in leadership); the tracked headcount is 6.

NameRoleGroup
Brent Ness
CEOLeadership
Andy Murillo
Director Of Market AccessLeadership
Ryan D. Bond
Chief Strategy OfficerLeadership
Leilani Ibarolle
VP FinanceLeadership
Premium access

Complete people profiles for Aclarion

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

IPO & Listings of Aclarion

Aclarion is a publicly listed company on the NASDAQ with ticker symbol ACON in USA, operating in the Technology services sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

  • IPO date22 Apr 2022
  • Listed onNASDAQ: ACON
  • Listed entityAclarion, Inc.
  • Exchange sectorTechnology services
  • ISINUS6551874091
  • Share price$2.14 (-4.68% on the day) · 2026-10-13
  • Market capitalisation$6.2M
  • EPS (diluted, trailing year)$-7.60
  • Volume (last session)21,361

Financials of Aclarion

Exchange-reported annual figures
YearRevenueNet incomeEBITDA
2025$75,730-$7.2M-$6.8M
2024$45,720-$7.0M-$5.3M
2023$75,400-$4.9M-$4.7M
2022$60,440-$7.1M-$5.4M
2021$60,290-$5.0M-$2.8M
Premium access

Detailed financial statements for Aclarion

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Timeline of Aclarion

4 dated milestones of Aclarion across 17 years, from founding to its latest funding, stage changes and deals.

  1. Founded Aclarion is founded.
  2. Funding First funding round of $3.3M.
  3. IPO Lists on the stock exchange (IPO).
  4. Funding Latest funding round, Post-IPO, of $20.0M.

Competitors of Aclarion

Aclarion has 3 listed competitors in our database, 2 of them funded. They include AIdoc, Lantheus and Vista.ai.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
aidoc.com2016New York, United States$424.5M
AI-based single-screen system is provided to streamline medical imaging.
lantheus.com2008Billerica, United States834
Developer of diagnostic imaging agents and targeted therapeutics
vista.ai2012Palo Alto, United States$8.7M13
AI-guided software is utilized to automate MRI exams for clinicians.
Premium access

Detailed competitors of Aclarion

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Aclarion

The website of Aclarion (aclarion.com) receives about 6.2K visits a month.

  • Monthly visits
    6.2K

    ▲ 65% vs previous month

Top companies in Clinical IT & Data Platforms

3 companies that operate in the same segment as Aclarion (Clinical IT & Data Platforms) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Employee health benefits are facilitated via a cloud-based platform.
2007Plymouth Meeting, Pennsylvania, United StatesUSD 228.3 M
Healthcare appointments are booked online via Zocdoc's platform.
2007New York, New York, United StatesUSD 425.97 MUSD 4.66 M1,365
Virtual physical therapy and digital pain care solutions are provided.
2015San Francisco, California, United StatesUSD 854.44 M1,746
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • ✓
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • ✓
    Full access to every database India & global coverage, advanced filters and rich profile details
  • ✓
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Aclarion

Premium access

Complete news archive for Aclarion

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Aclarion

Aclarion was founded in 2008 and raised its 1st funding round 10 years after it was founded.

Aclarion is headquartered in Broomfield, United States. It is registered at Broomfield, Colorado, United States.

Brent Ness is the CEO of Aclarion, as recorded in our data.

Aclarion is a funded company, having raised a total of $3.26M across 4 funding rounds to date. The company's 1st funding round was a Series A of $3.26M, raised on May 2018.

Aclarion has 6 employees.

Annual revenue of Aclarion is $75.73K as on Dec 31, 2025.

Founded in 2008 and based in Broomfield, United States, Aclarion operates in the healthcare technology sector. Software is developed to support radiology image analysis through a SaaS model. Raw medical imaging data is processed into metabolic biomarkers, with features enabled for MRI diagnosis and diagnostic analysis. Assistance is offered to providers for enhanced imaging and diagnostic workflows.

Aclarion's top competitors include AIdoc, Vista.ai and Lantheus.

Aclarion offers NOCISCAN.

Yes, Aclarion is publicly traded on NASDAQ under the ticker symbol ACON.

Aclarion operates through Aclarion, Inc..

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available